Clinical Trial Update: Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of KI1107 in patients with dyslipidemias whose triglycerides are not adequately controlled with rosuvastatin whi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• KI1107

Snippet

Sponsor: Kuhnil Pharmaceutical Co., Ltd. | Conditions: Dyslipidemias | Phase 3 | Status: COMPLETED